SAFETY of DENGUE VACCINE (CYD-TDV) in ASIA: A SYSTEMATIC REVIEW

SAFETY of DENGUE VACCINE (CYD-TDV) in ASIA: A SYSTEMATIC REVIEW

Show other versions (1)

The use of the vaccine in Asia is still very much limited and remained controversial due to its safety, which has yet been properly assessed and evaluated. Hence, the objective of this review is to assess the safety of the CYD-TDV dengue vaccine of the efficacy trials conducted in Asia. A total of 3...

Full description

Bibliographic Details
Main Authors: Abdul Majid, M.Sh (Author), Abdul Rahim, S.Sh.S (Author), Azhar, Z.I (Author), Ghazi, H.F (Author), Hassan, M.R (Author), Jeffree, M.S (Author), Li, H.Y (Author), Madrim, M.F (Author), Wan Ismail, W.R (Author)
Format: Article
Language:English
Published: Saint Petersburg Pasteur Institute 2021
Series:Russian Journal of Infection and Immunity
Subjects:
adolescent
adult
Adults
antibody titer
Asia
child
Children
cyd tdv
CYD-TDV
dengue vaccine
Dengue vaccine
Dengue virus 2
Dengue virus 3
Dengue virus 4
dose response
drug efficacy
drug safety
fever
headache
human
injection site erythema
injection site pain
injection site swelling
meta analysis
myalgia
phase 2 clinical trial (topic)
phase 3 clinical trial (topic)
Review
risk factor
Safety
seroprevalence
serotype
systematic review
vaccine immunogenicity
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items